News and Events

March 2, 2023

NIH Director’s blog: What Clinical Research Comes Next for Helping People with Long COVID

Three leaders at the NIH explain how patient experiences have guided and will continue to guide RECOVER's efforts to understand, diagnose, prevent, and treat Long COVID.

February 16, 2023

NIH RECOVER research identifies potential long COVID disparities

Black and Hispanic Americans appear to experience more symptoms and health problems related to Long COVID than white people but are not as likely to be diagnosed with the condition.

October 31, 2022

RECOVER program takes first steps in advancing toward clinical trials to better understand Long COVID

RECOVER will launch several clinical trials to find treatments for five of the most burdensome symptom clusters identified by people suffering from Long COVID.

August 12, 2022

RECOVER Research Awards

RECOVER has awarded over $37 million in funding to more than 40 pathobiology studies that will further our understanding of how COVID affects different body tissues and organs.

August 2, 2022

Duke Selected as RECOVER Clinical Trials Data Coordinating Center

The Duke Clinical Research Institute (DCRI) will oversee RECOVER’s efforts to find safe and effective treatments for Long COVID symptoms.

June 7, 2022

NIH Director’s Blog: Using AI to Advance Understanding of Long COVID Syndrome

NIH Director Lawrence Tabak, DDS, PhD, describes how artificial intelligence (AI) can help us learn why some people are more likely to have Long COVID.

May 16, 2022

RECOVER Publication: Scientists use Electronic Health Records and Machine Learning to Better Define Long COVID

RECOVER researchers created computer models to find patterns in health data that can identify people likely to have Long COVID.

March 28, 2022

RECOVER Adult Study Protocol Available

This publication describes the study plan RECOVER researchers follow when answering questions about how Long COVID affects people aged 18 years and older.